Detalles de la búsqueda
1.
A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease.
BMC Neurol;
16: 92, 2016 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27312378
2.
Using 'dead or dependent' as an outcome measure in clinical trials in Parkinson's disease.
J Neurol Neurosurg Psychiatry;
86(2): 180-5, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24854405
3.
Lending a hand: can DASH items help ABILHAND improve manual ability measurement in multiple sclerosis?
Mult Scler;
21(5): 612-21, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25583836
4.
Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease.
Acta Neuropathol;
127(2): 235-41, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24240814
5.
Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures.
Mult Scler;
19(12): 1632-9, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23530002
6.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Mult Scler;
19(13): 1773-83, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23574800
7.
A systematic review of biomarkers for disease progression in Parkinson's disease.
BMC Neurol;
13: 35, 2013 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23587062
8.
Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods.
Alzheimers Dement;
9(1 Suppl): S4-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23253777
9.
Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory.
Alzheimers Dement;
9(1 Suppl): S10-20, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23253779
10.
Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach.
Alzheimers Dement;
9(1 Suppl): S56-60, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23391006
11.
Multiple sclerosis and extract of cannabis: results of the MUSEC trial.
J Neurol Neurosurg Psychiatry;
83(11): 1125-32, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22791906
12.
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Value Health;
15(8): 1084-91, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23244811
13.
Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studies.
Clin Med (Lond);
12(3): 210-5, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22783770
14.
Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial.
JAMA Neurol;
79(12): 1232-1241, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36315128
15.
Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progression.
Value Health;
14(5): 621-30, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21839398
16.
Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort.
BMC Neurol;
10: 88, 2010 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-20929556
17.
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.
Pract Neurol;
15(4): 273-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26101071
18.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: No.
Mult Scler;
20(9): 1165-6, 2014 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27352433
19.
Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis.
Lancet Neurol;
18(8): 736-747, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31301748
20.
Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study.
BMJ Open;
9(10): e029740, 2019 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31594876